Tecan’s greenhouse gas emissions reduction targets validated by the Science Based Targets initiative
14 Dezember 2023 - 5:55PM
Tecan’s greenhouse gas emissions reduction targets validated by the
Science Based Targets initiative
Männedorf, Switzerland, December 14, 2023 – The
Tecan Group (SIX Swiss Exchange: TECN) announced that its
greenhouse gas emissions reduction targets have been validated by
the Science Based Targets initiative.
Tecan improves people’s lives and health by empowering customers
to scale healthcare innovation globally from life science to the
clinic and strives to match this positive impact with responsible
business practices. In 2022, Tecan committed to reduce in line with
climate science the greenhouse gas (GHG) emissions generated by its
business activities. The Science Based Targets initiative has now
validated Tecan’s targets:
Overall Net Zero Target Tecan Group Ltd.
commits to reach net-zero greenhouse gas emissions across the value
chain by 2050. Near-Term Targets Tecan Group Ltd.
commits to reduce absolute scope 1 and 2 GHG emissions 42% by 2030
from a 2022 base year. Tecan also commits to increase active annual
sourcing of renewable electricity from 34% in 2022 to 100% by 2025,
and to continue active annual sourcing of 100% renewable
electricity through 2030. Tecan finally commits to reduce absolute
scope 3 GHG emissions 42% by 2030 from a 2022 base year.
Long-Term Targets Tecan Group Ltd. commits to
reduce absolute scope 1, 2 and 3 GHG emissions 90% by 2050 from a
2022 base year.
Tecan CEO Achim von Leoprechting says: “Limiting global
temperature raise to 1.5°C above pre-industrial average
temperatures is still possible if the global community acts
decisively. Tecan is committed to playing its part in this effort.
We know that reduction of direct emissions is also important to
many of our customers, and we’re passionate about working with our
customers and suppliers in transitioning to a low-carbon
economy.”
Actions to support this effort as well as further details
regarding Tecan’s environmental management, governance practices
and social impact are described in Tecan’s Sustainability Report,
which is part of Tecan’s Annual Report, as well as at the
sustainability page on Tecan.com. Tecan will continue to
communicate transparently on these topics at least annually, with
the next update in March, 2024.About the Science Based
Targets initiative (SBTi) The SBTi is a collaboration
between CDP, the United Nations Global Compact, World Resources
Institute (WRI), and the World Wide Fund for Nature (WWF) and one
of the We Mean Business Coalition commitments. The SBTi defines and
promotes best practice in science-based target setting, offers
resources and guidance to reduce barriers to adoption, and
independently assesses and approves companies’ targets.
About TecanTecan
(www.tecan.com) improves people’s lives and health by empowering
customers to scale healthcare innovation globally from life science
to the clinic. Tecan is a pioneer and global leader in laboratory
automation. As an original equipment manufacturer (OEM), Tecan is
also a leader in developing and manufacturing OEM instruments,
components and medical devices that are then distributed by partner
companies. Founded in Switzerland in 1980, the company has more
than 3,500 employees, with manufacturing, research and development
sites in Europe, North America and Asia, and maintains a sales and
service network in over 70 countries. In 2022, Tecan generated
sales of CHF 1,144 million (USD 1,192 million; EUR 1,144 million).
Registered shares of Tecan Group are traded on the SIX Swiss
Exchange (TECN; ISIN CH0012100191).
For further information:
Tecan GroupMartin BrändleSenior Vice President,
Corporate Communications & IRTel. +41 (0) 44 922 84 30Fax +41
(0) 44 922 88 89investor@tecan.comwww.tecan.com
Tecan (LSE:0QLN)
Historical Stock Chart
Von Nov 2024 bis Dez 2024
Tecan (LSE:0QLN)
Historical Stock Chart
Von Dez 2023 bis Dez 2024
